Unichem Laboratories’ arm recalls 18,960 bottles of hypertension drug in US

06 Oct 2022 Evaluate

Unichem Laboratories’ subsidiary -- Unichem Pharmaceuticals USA Inc is recalling 18,960 bottles of the hypertension treatment medication Clonidine Hydrochloride tablets in the American market. The recall is due to product mix-up.

As per the US Food and Drug Administration (USFDA), 0.2 mg strength Clonidine Hydrochloride Tablets, USP were found in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets. The affected lot of tables have been manufactured by Unichem Laboratories in its Goa based plant and distributed in the US market by New Jersey-based Unichem Pharmaceuticals USA Inc.

As per the USFDA, the company has initiated the Class III recall on September 19 across the US.A Class III recall is initiated in a ‘situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences’. According to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019. It is the largest market globally for pharmaceutical products.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

585.00 -3.40 (-0.58%)
02-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6260.00
Cipla 1419.55
Zydus Lifesciences 988.00
Lupin 1647.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.